CE Mark approval Europe

Medovex Corporation Schedules First Human Case for DenerveX™ System

ATLANTA, GA–(Marketwired – Jun 27, 2017) – Medovex Corp. (NASDAQ: MDVX) (“Medovex” or the “Company”), a developer of medical technology…